Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment
- PMID: 40047999
- PMCID: PMC11885406
- DOI: 10.1007/s00520-025-09317-9
Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment
Abstract
Purpose: This study reports on the results from our data-driven approach that identified perturbations in neuroactive ligand-receptor interaction and renin-angiotensin system (RAS) pathways in oncology patients with and without self-reported cancer-related cognitive impairment (CRCI).
Methods: In a sample of oncology patients receiving chemotherapy (n = 1343), the Attentional Function Index (AFI) was used to assess CRCI. Patients were grouped into low (AFI score of < 5) versus high (AFI score of > 7.5) levels of cognitive function. Gene expression analyses were done using RNA-seq (n = 185) and microarray (n = 158) technologies. Pathway impact analysis was used to evaluate for perturbations in biological pathways associated with self-reported CRCI.
Results: The combined pathway impact analysis revealed that the neuroactive ligand-receptor interaction and RAS pathways were significantly perturbed between the patients with low versus high AFI scores.
Conclusions: Findings from this study suggest that in addition to inflammatory pathways, numerous mechanisms may contribute to the underlying mechanisms for the development and/or persistence of self-reported CRCI.
Keywords: Cancer; Chemotherapy; Cognitive dysfunction; Cognitive impairment; Neuroinflammation; Renin angiotensin system.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Committee on Human Research at the University of California, San Francisco. Consent to participate: Written informed consent was obtained from the patients. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
Cancer-related cognitive impairment is associated with perturbations in inflammatory pathways.Cytokine. 2021 Dec;148:155653. doi: 10.1016/j.cyto.2021.155653. Epub 2021 Aug 10. Cytokine. 2021. PMID: 34388477 Free PMC article.
-
Self-reported cancer-related cognitive impairment is associated with perturbed neurotransmission pathways.J Neural Transm (Vienna). 2025 Feb;132(2):275-286. doi: 10.1007/s00702-024-02824-9. Epub 2024 Sep 26. J Neural Transm (Vienna). 2025. PMID: 39325169 Free PMC article.
-
Neurodegenerative disease pathways are perturbed in patients with cancer who self-report cognitive changes and anxiety: A pathway impact analysis.Cancer. 2024 Aug 15;130(16):2834-2847. doi: 10.1002/cncr.35336. Epub 2024 Apr 27. Cancer. 2024. PMID: 38676932
-
Chemotherapy-related cognitive impairment in older patients with cancer.J Geriatr Oncol. 2016 Jul;7(4):270-80. doi: 10.1016/j.jgo.2016.04.008. Epub 2016 Jul 5. J Geriatr Oncol. 2016. PMID: 27197918 Free PMC article. Review.
-
Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.Ann Oncol. 2019 Dec 1;30(12):1925-1940. doi: 10.1093/annonc/mdz410. Ann Oncol. 2019. PMID: 31617564 Free PMC article. Review.
Cited by
-
Early-life exposure to polypropylene nanoplastics induces neurodevelopmental toxicity in mice and human iPSC-derived cerebral organoids.J Nanobiotechnology. 2025 Jul 1;23(1):474. doi: 10.1186/s12951-025-03561-1. J Nanobiotechnology. 2025. PMID: 40597354 Free PMC article.
-
Identification of m6 A-regulated ferroptosis biomarkers for prognosis in laryngeal cancer.BMC Cancer. 2025 Apr 14;25(1):694. doi: 10.1186/s12885-025-14134-8. BMC Cancer. 2025. PMID: 40229748 Free PMC article.
References
-
- Cerulla Torrente N, Navarro Pastor JB, de la Osa CN (2020) Systematic review of cognitive sequelae of non-central nervous system cancer and cancer therapy. J Cancer Surviv 14(4):464–482. 10.1007/s11764-020-00870-2 - PubMed
-
- Cheung YT, Shwe M, Tan YP, Fan G, Ng R, Chan A (2012) Cognitive changes in multiethnic Asian breast cancer patients: a focus group study. Ann Oncol 23(10):2547–2552. 10.1093/annonc/mds029 - PubMed
-
- Ren X, Boriero D, Chaiswing L, Bondada S, St. Clair DK, Butterfield DA (2019) Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (“chemobrain”), a condition that significantly impairs the quality of life of many cancer survivors. Biochimica et Biophysica Acta (BBA) – Mol Basis Dis 1865(6):1088–97. 10.1016/j.bbadis.2019.02.007 - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical